October 16th 2024
The addition of T4001, an investigation cancer vaccine, to avelumab did not improve progression-free survival vs avelumab alone in cervical and anogenital tumors.
October 8th 2024
The World Health Organization updated their guidelines to include CINtec PLUS Cytology for gynecologic cancer prevention.
September 15th 2024
Pembrolizumab plus chemoradiotherapy improved survival in patients with previously untreated, high-risk locally advanced cervical cancer.
August 19th 2024
Bintrafusp alfa induced responses in recurrent/metastatic cervical cancer, supporting the need for further research into TGF-β-targeted therapies.
May 26th 2024
A breakthrough device designation has been granted by the FDA to Teal Wand, an at-home screening test for cervical cancer.
NT-I7 Enhances CAR T-Cell Efficacy in DLBCL
Nurses, Talk AEs, Interstitial Lung Disease, Before Treating With T-DXd
Non-Operative Management of Rectal Cancer Does Not Worsen Distant RFS
Belrestotug/Dostarlimab Improves Responses in PD-L1–High Lung Cancer